Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 10,680 | 4,740 | 4,106 | 4,402 | 2,431 |
| Gross Profit | 10,680 | 4,740 | 4,106 | 4,402 | 2,431 |
| Operating Expenses | 111,407 | 71,832 | 46,231 | 36,365 | 30,213 |
| Operating Income | -100,727 | -67,092 | -42,125 | -31,963 | -27,782 |
| Interest Expense | 1,752 | 1,696 | 1,268 | 1,637 | 2,220 |
| Other Income | 4,330 | 2,190 | 441 | 138 | 10 |
| Pre-tax Income | -98,149 | -66,598 | -42,952 | -33,462 | -29,992 |
| Net Income Continuous | -98,149 | -66,598 | -42,952 | -33,462 | -29,992 |
| Net Income | $-98,149 | $-66,598 | $-42,952 | $-33,462 | $-29,992 |
| EPS Basic Total Ops | -1.44 | -1.19 | -1.02 | -1.05 | -1.18 |
| EPS Basic Continuous Ops | -1.44 | -1.19 | -1.02 | -1.05 | -1.18 |
| EPS Diluted Total Ops | -1.44 | -1.19 | -1.02 | -1.05 | -1.18 |
| EPS Diluted Continuous Ops | -1.44 | -1.19 | -1.02 | -1.05 | -1.18 |
| EPS Diluted Before Non-Recurring Items | -1.44 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-98,277 | $-66,105 | $-41,098 | $-30,772 | $-26,919 |